These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 12046635

  • 1. "As needed" pharmacotherapy combined with stimulus control treatment in chronic insomnia--assessment of a novel intervention strategy in a primary care setting.
    Hajak G, Bandelow B, Zulley J, Pittrow D.
    Ann Clin Psychiatry; 2002 Mar; 14(1):1-7. PubMed ID: 12046635
    [Abstract] [Full Text] [Related]

  • 2. Eight weeks of non-nightly use of zolpidem for primary insomnia.
    Walsh JK, Roth T, Randazzo A, Erman M, Jamieson A, Scharf M, Schweitzer PK, Ware JC.
    Sleep; 2000 Dec 15; 23(8):1087-96. PubMed ID: 11145323
    [Abstract] [Full Text] [Related]

  • 3. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB, Roth T, Vogel GW, Walsh JK.
    J Clin Psychiatry; 1994 May 15; 55(5):192-9. PubMed ID: 8071269
    [Abstract] [Full Text] [Related]

  • 4. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison.
    Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW.
    Arch Intern Med; 2004 Sep 27; 164(17):1888-96. PubMed ID: 15451764
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T, Soubrane C, Titeux L, Walsh JK, Zoladult Study Group.
    Sleep Med; 2006 Aug 27; 7(5):397-406. PubMed ID: 16815744
    [Abstract] [Full Text] [Related]

  • 6. Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age.
    Blumer JL, Findling RL, Shih WJ, Soubrane C, Reed MD.
    Pediatrics; 2009 May 27; 123(5):e770-6. PubMed ID: 19403468
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
    Walsh JK, Soubrane C, Roth T.
    Am J Geriatr Psychiatry; 2008 Jan 27; 16(1):44-57. PubMed ID: 18165461
    [Abstract] [Full Text] [Related]

  • 8. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
    Dorsey CM, Lee KA, Scharf MB.
    Clin Ther; 2004 Oct 27; 26(10):1578-86. PubMed ID: 15598474
    [Abstract] [Full Text] [Related]

  • 9. A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.
    Hajak G, Hedner J, Eglin M, Loft H, Stórustovu SI, Lütolf S, Lundahl J, Gaboxadol Study 99775 Group.
    Sleep Med; 2009 Aug 27; 10(7):705-12. PubMed ID: 19346160
    [Abstract] [Full Text] [Related]

  • 10. Polysomnographic study of intermittent zolpidem treatment in primary sleep maintenance insomnia.
    Parrino L, Smerieri A, Giglia F, Milioli G, De Paolis F, Terzano MG.
    Clin Neuropharmacol; 2008 Aug 27; 31(1):40-50. PubMed ID: 18303490
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial.
    Lydiard RB, Lankford DA, Seiden DJ, Landin R, Farber R, Walsh JK.
    J Clin Sleep Med; 2006 Jul 15; 2(3):309-15. PubMed ID: 17561543
    [Abstract] [Full Text] [Related]

  • 12. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States.
    Jhaveri M, Seal B, Pollack M, Wertz D.
    Curr Med Res Opin; 2007 Jun 15; 23(6):1431-43. PubMed ID: 17559740
    [Abstract] [Full Text] [Related]

  • 13. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T, Seiden D, Sainati S, Wang-Weigand S, Zhang J, Zee P.
    Sleep Med; 2006 Jun 15; 7(4):312-8. PubMed ID: 16709464
    [Abstract] [Full Text] [Related]

  • 14. Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms.
    Barkin RL.
    Am J Ther; 2007 Jun 15; 14(3):299-305. PubMed ID: 17515707
    [Abstract] [Full Text] [Related]

  • 15. Management of chronic insomnia in elderly persons.
    Bain KT.
    Am J Geriatr Pharmacother; 2006 Jun 15; 4(2):168-92. PubMed ID: 16860264
    [Abstract] [Full Text] [Related]

  • 16. Effect of zolpidem on sleep architecture and its next-morning residual effect in insomniac patients: a randomized crossover comparative study with brotizolam.
    Uchimura N, Nakajima T, Hayash K, Nose I, Hashizume Y, Ohyama T, Habukawa M, Kotorii N, Kuwahara H, Maeda H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan 15; 30(1):22-9. PubMed ID: 16048734
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of indiplon in older adults with primary insomnia.
    Walsh JK, Moscovitch A, Burke J, Farber R, Roth T.
    Sleep Med; 2007 Nov 15; 8(7-8):753-9. PubMed ID: 17825616
    [Abstract] [Full Text] [Related]

  • 18. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.
    Roger M, Attali P, Coquelin JP.
    Clin Ther; 1993 Nov 15; 15(1):127-36. PubMed ID: 8458042
    [Abstract] [Full Text] [Related]

  • 19. Experience with zolpidem 'as needed' in primary care settings.
    Hajak G, Geisler P.
    CNS Drugs; 2004 Nov 15; 18 Suppl 1():35-40; discussion 41, 43-5. PubMed ID: 15291012
    [Abstract] [Full Text] [Related]

  • 20. Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study.
    Voshaar RC, van Balkom AJ, Zitman FG.
    Eur Neuropsychopharmacol; 2004 Aug 15; 14(4):301-6. PubMed ID: 15163440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.